Cargando…

Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes

Background: Torsades de pointes (TdP) is a life-threatening ventricular tachycardia occurring in long QT-syndrome patients. It usually develops when multiple QT-prolonging factors are concomitantly present, more frequently drugs and electrolyte imbalances. Since proton–pump inhibitors (PPIs)-associa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lazzerini, Pietro E., Bertolozzi, Iacopo, Finizola, Francesco, Acampa, Maurizio, Natale, Mariarita, Vanni, Francesca, Fulceri, Rosella, Gamberucci, Alessandra, Rossi, Marco, Giabbani, Beatrice, Caselli, Michele, Lamberti, Ilaria, Cevenini, Gabriele, Laghi-Pasini, Franco, Capecchi, Pier L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922007/ https://www.ncbi.nlm.nih.gov/pubmed/29731714 http://dx.doi.org/10.3389/fphar.2018.00363

Ejemplares similares

Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin‐6–Mediated Changes in Connexin Expression
por: Lazzerini, Pietro Enea, et al.
Publicado: (2019)

Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis
por: Lazzerini, Pietro Enea, et al.
Publicado: (2016)

Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes
por: Lazzerini, Pietro Enea, et al.
Publicado: (2020)

Transient Hypogonadism Is Associated With Heart Rate–Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men
por: Lazzerini, Pietro Enea, et al.
Publicado: (2021)

Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts
por: Gentile, Daniela, et al.
Publicado: (2017)

Unravelling Atrioventricular Block Risk in Inflammatory Diseases: Systemic Inflammation Acutely Delays Atrioventricular Conduction via a Cytokine‐Mediated Inhibition of Connexin43 Expression
por: Lazzerini, Pietro Enea, et al.
Publicado: (2021)

Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
por: Lazzerini, Pietro Enea, et al.
Publicado: (2016)

Drug-Associated QTc Prolongation in Geriatric Hospitalized Patients: A Cross-Sectional Study in Internal Medicine
por: Rossi, Marco, et al.
Publicado: (2021)

Long QT Syndrome: An Emerging Role for Inflammation and Immunity
por: Lazzerini, Pietro Enea, et al.
Publicado: (2015)

Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls
por: Lazzerini, Pietro Enea, et al.
Publicado: (2016)

Risk of QTc Interval Prolongation Associated With Circulating Anti‐Ro/SSA Antibodies Among US Veterans: An Observational Cohort Study
por: Lazzerini, Pietro Enea, et al.
Publicado: (2021)

Commentary: Systemic effects of IL-17 in inflammatory arthritis
por: Lazzerini, Pietro Enea, et al.
Publicado: (2019)

Anti-Ro/SSA Antibodies and the Autoimmune Long-QT Syndrome
por: Lazzerini, Pietro Enea, et al.
Publicado: (2021)

Inflammatory cytokines and cardiac arrhythmias: the lesson from COVID-19
por: Lazzerini, Pietro Enea, et al.
Publicado: (2022)

Emerging Arrhythmic Risk of Autoimmune and Inflammatory Cardiac Channelopathies
por: Lazzerini, Pietro Enea, et al.
Publicado: (2018)

Reply: The Role of Inflammation and Gender Differences in the Pathogenesis of Cardiac Arrhythmias
por: Lazzerini, Pietro Enea, et al.
Publicado: (2023)

Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities
por: Qu, Yongxia Sarah, et al.
Publicado: (2019)

Interleukin-6 Elevation Is a Key Pathogenic Factor Underlying COVID-19-Associated Heart Rate-Corrected QT Interval Prolongation
por: Lazzerini, Pietro Enea, et al.
Publicado: (2022)

Editorial: Insights in General Cardiovascular Medicine: 2021
por: Wang, Lijun, et al.
Publicado: (2022)

Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation
por: Aromolaran, Ademuyiwa S., et al.
Publicado: (2018)

Isolated atrioventricular block of unknown origin in the adult and autoimmunity: diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA–associated cases
por: Lazzerini, Pietro Enea, et al.
Publicado: (2015)

Torsades de Pointes With a Normal Magnesium Level in the Setting of Short Bowel Syndrome
por: Siraj, Talhah Z, et al.
Publicado: (2021)

Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?”
por: Capecchi, Pier Leopoldo, et al.
Publicado: (2021)

A tale of 2 torsades: How to approach a patient with torsades de pointes and distinguish between classical and pseudo–torsades de pointes
por: Scheinman, Melvin, et al.
Publicado: (2022)

Fir(e)ing the Rhythm: Inflammatory Cytokines and Cardiac Arrhythmias
por: Lazzerini, Pietro Enea, et al.
Publicado: (2023)

Atrial Cardiopathy and Sympatho-Vagal Imbalance in Cryptogenic Stroke: Pathogenic Mechanisms and Effects on Electrocardiographic Markers
por: Acampa, Maurizio, et al.
Publicado: (2018)

Perioperative stroke and hyperhomocysteinemia: a possible pathogenic link
por: Acampa, Maurizio, et al.
Publicado: (2018)

How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion
por: Acampa, Maurizio, et al.
Publicado: (2017)

Ondansetron induced torsades de pointes
por: Patel, Eshan, et al.
Publicado: (2019)

Failure to Treat Torsades de Pointes
por: Yazdan-Ashoori, Payam, et al.
Publicado: (2012)

Loperamide-Induced Torsades de Pointes
por: Isang, Emmanuel, et al.
Publicado: (2021)

Nearly Fatal Torsade de Pointes with Sotalol
por: Strohmer, Bernhard, et al.
Publicado: (2003)

DOTHIEPIN, QT PROLONGATION AND TORSADES DE POINTES
por: Andrade, Chittaranjan, et al.
Publicado: (1999)

Leadless pacemaker–induced torsades de pointes
por: Burkman, Gregory, et al.
Publicado: (2020)

Amiodarone: Torsade de pointes: case report
Publicado: (2022)

Torsade de Pointes Due to Hypokalemia and Hypomagnesemia
por: Cabahug, Mary Crista, et al.
Publicado: (2022)

Successful Management of Refractory Torsades De Pointes Due to Drug-Induced Long QT Syndrome Guided by Point-of-Care Monitoring of Ionized Magnesium
por: Matsuura, Chiho, et al.
Publicado: (2021)

Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry
por: Girolami, Francesca, et al.
Publicado: (2022)

Cryptogenic stroke as a working diagnosis: the need for an early and comprehensive diagnostic work-up
por: Acampa, Maurizio, et al.
Publicado: (2023)

Editorial: New challenges and future perspectives in autonomic neuroscience
por: Salvini, Viola, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_160d6tp5r6692ant7c44uubpab